학술논문

The effect of sample size on polygenic hazard models for prostate cancer
Document Type
article
Source
European Journal of Human Genetics. 28(10)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Prostate Cancer
Cancer
Aging
Urologic Diseases
Clinical Trials as Topic
Genome-Wide Association Study
Humans
Male
Models
Genetic
Multifactorial Inheritance
Polymorphism
Single Nucleotide
Proportional Hazards Models
Prostatic Neoplasms
Sample Size
Australian Prostate Cancer BioResource
PRACTICAL Consortium
Genetics
Clinical Sciences
Genetics & Heredity
Clinical sciences
Language
Abstract
We determined the effect of sample size on performance of polygenic hazard score (PHS) models in prostate cancer. Age and genotypes were obtained for 40,861 men from the PRACTICAL consortium. The dataset included 201,590 SNPs per subject, and was split into training and testing sets. Established-SNP models considered 65 SNPs that had been previously associated with prostate cancer. Discovery-SNP models used stepwise selection to identify new SNPs. The performance of each PHS model was calculated for random sizes of the training set. The performance of a representative Established-SNP model was estimated for random sizes of the testing set. Mean HR98/50 (hazard ratio of top 2% to average in test set) of the Established-SNP model increased from 1.73 [95% CI: 1.69-1.77] to 2.41 [2.40-2.43] when the number of training samples was increased from 1 thousand to 30 thousand. Corresponding HR98/50 of the Discovery-SNP model increased from 1.05 [0.93-1.18] to 2.19 [2.16-2.23]. HR98/50 of a representative Established-SNP model using testing set sample sizes of 0.6 thousand and 6 thousand observations were 1.78 [1.70-1.85] and 1.73 [1.71-1.76], respectively. We estimate that a study population of 20 thousand men is required to develop Discovery-SNP PHS models while 10 thousand men should be sufficient for Established-SNP models.